Namho Kim is from Seoul, Korea, and received his B.S. in bioengineering from Lehigh University (Bethlehem, PA) in 2008. In 2010, he received his Master's degree in biomedical engineering at Purdue under the supervision of Dr. Kinam Park.Upon graduating from Purdue, Namho joined a venture called BioActs located in Incheon, Korea. As a researcher at BioActs, Namho helped develop a novel cell apoptosis detection kit and also participated in overseas operations, securing numerous deals for collaborative work and/or export. To expand upon his research abilities, Namho joined Korea Institute of Science and Technology in 2012. At KIST, his main area of research was nanoparticle formation and siRNA delivery for cancer therapy. Namho is currently a Ph.D. candidate at Johns Hopkins University under the guidance of Dr. Justin Hanes. With continued interest in the field of drug delivery, he has been focusing on gene therapy for lung (cystic fibrosis, allergic asthma, fibrosis) and brain diseases (Parkinson's). In near future, Namho hopes to pursue a career in biotech venture capital, or consulting in area of FDA regulatory affairs and bio/biomedical technology, and one day become a leading entrepreneur in the biotech industry.